Smith Chas P & Associates Pa Cpas Medtronic PLC Transaction History

Smith Chas P & Associates Pa Cpas

$1.77 Billion
Q3 2024

A detailed history of Smith Chas P & Associates Pa Cpas transactions in Medtronic PLC stock. As of the latest transaction made, Smith Chas P & Associates Pa Cpas holds 9,936 shares of MDT stock, worth $835,716. This represents 0.05% of its overall portfolio holdings.

Number of Shares

9,936

Previous 11,140 10.81%

Holding current value

$835,716

Previous $876,000 2.05%

% of portfolio

0.05%

Previous 0.05%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	SELL	$76.84 - $91.03 $92,515 - $109,600	-1,204 Reduced 10.81%	9,936 $894,000
Q2 2024 Jul 29, 2024	SELL	$78.71 - $87.02 $223,693 - $247,310	-2,842 Reduced 20.33%	11,140 $876,000
Q1 2024 Apr 25, 2024	SELL	$82.84 - $88.09 $70,414 - $74,876	-850 Reduced 5.73%	13,982 $1.22 Million
Q4 2023 Feb 01, 2024	SELL	$69.43 - $83.43 $22.7 Million - $27.3 Million	-326,971 Reduced 95.66%	14,832 $1.22 Million
Q3 2023 Nov 02, 2023	SELL	$78.22 - $90.4 $286,598 - $331,225	-3,664 Reduced 1.06%	341,803 $26.8 Million
Q2 2023 Jul 31, 2023	BUY	$79.47 - $91.38 $647,521 - $744,564	8,148 Added 2.42%	345,467 $30.4 Million
Q1 2023 Apr 27, 2023	BUY	$76.72 - $87.58 $998,510 - $1.14 Million	13,015 Added 4.01%	337,319 $27.2 Million
Q4 2022 Jan 12, 2023	BUY	$76.18 - $87.74 $342,657 - $394,654	4,498 Added 1.41%	324,304 $25.2 Million
Q3 2022 Nov 22, 2022	BUY	$80.75 - $95.31 $1.12 Million - $1.33 Million	13,923 Added 4.55%	319,806 $25.8 Million
Q2 2022 Jul 15, 2022	BUY	$87.4 - $113.09 $1.4 Million - $1.81 Million	15,976 Added 5.51%	305,883 $27.5 Million
Q1 2022 May 12, 2022	BUY	$100.58 - $112.38 $5.48 Million - $6.13 Million	54,519 Added 23.16%	289,907 $32.2 Million
Q4 2021 Feb 07, 2022	BUY	$99.53 - $127.75 $727,663 - $933,980	7,311 Added 3.21%	235,388 $24.4 Million
Q3 2021 Oct 12, 2021	BUY	$122.75 - $135.17 $913,751 - $1.01 Million	7,444 Added 3.37%	228,077 $28.6 Million
Q2 2021 Jul 23, 2021	BUY	$118.19 - $131.5 $561,166 - $624,362	4,748 Added 2.2%	220,633 $27.4 Million
Q1 2021 May 11, 2021	BUY	$111.18 - $119.74 $937,914 - $1.01 Million	8,436 Added 4.07%	215,885 $25.5 Million
Q4 2020 Feb 10, 2021	BUY	$100.57 - $117.14 $376,131 - $438,103	3,740 Added 1.84%	207,449 $24.3 Million
Q3 2020 Nov 10, 2020	BUY	$90.13 - $108.78 $100,044 - $120,745	1,110 Added 0.55%	203,709 $21.2 Million
Q2 2020 Aug 13, 2020	BUY	$84.11 - $103.33 $131,632 - $161,711	1,565 Added 0.78%	202,599 $18.6 Million
Q1 2020 May 11, 2020	BUY	$72.92 - $121.3 $3.57 Million - $5.94 Million	48,954 Added 32.19%	201,034 $18.1 Million
Q4 2019 Feb 04, 2020	BUY	$104.49 - $114.54 $1.63 Million - $1.79 Million	15,627 Added 11.45%	152,080 $17.3 Million
Q3 2019 Nov 06, 2019	BUY	$98.02 - $111.18 $1.35 Million - $1.53 Million	13,748 Added 11.2%	136,453 $14.8 Million
Q2 2019 Aug 09, 2019	BUY	$84.15 - $99.38 $10.1 Million - $11.9 Million	120,100 Added 4610.36%	122,705 $12 Million
Q1 2019 May 08, 2019	BUY	$82.45 - $93.79 $214,782 - $244,322	2,605 New	2,605 $237,000

Others Institutions Holding MDT

# of Institutions

2,283

Shares Held

1.02B

Call Options Held

8.05M

Put Options Held

7.19M

View Full List

About Medtronic plc

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $112B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

More about MDT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith Chas P & Associates Pa Cpas, based on Form 13F filings with the SEC.

News

Stay updated on Smith Chas P & Associates Pa Cpas with notifications on news.

Account

Smith Chas P & Associates Pa Cpas Medtronic PLC Transaction History